Zinbryta (daclizumab) is a medication used to treat relapsing forms of multiple sclerosis (MS) in adults. It's no longer available in the United States, because it was discontinued.
Relapsing forms of multiple sclerosis (MS)
Relapsing forms of multiple sclerosis (MS)
Relapsing forms of multiple sclerosis (MS)
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.